<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-13T04:07:36Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.43970" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.43970</identifier>
    <datestamp>2026-07-27T09:59:39Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-07-27</dc:date>
  <dc:title>De-identified dataset and analysis code for: Nonlinear Association Between Fever-to-IVIG Interval and Clinical Outcomes in Kawasaki Disease &amp;mdash; A Retrospective Cohort Study of 6,921 Children</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.43970</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This dataset supports the article &amp;quot;Nonlinear Association Between Fever-to-IVIG Interval and Clinical Outcomes in Kawasaki Disease: A Retrospective Cohort Study of 6,921 Children&amp;quot; (submitted to BMC Medicine). It comprises a de-identified, patient-level analytical dataset from a single-center retrospective cohort of 6,921 children diagnosed with Kawasaki disease (KD) and treated with initial intravenous immunoglobulin (IVIG, 2 g/kg) at Wuhan Children's Hospital between December 2012 and November 2025. The study investigates the nonlinear (U-shaped) association between the fever-to-IVIG interval and clinical outcomes, including IVIG resistance, coronary artery dilation (maximum Z-score &amp;gt;2.0), and aneurysm-level coronary involvement.The dataset contains one record per patient (6,921 rows &amp;times; 44 variables), covering demographics (age in integer months, sex), principal clinical features, the primary exposure (fever-to-IVIG interval, days), timing variables, first-available pre-IVIG laboratory values (complete blood count, inflammatory markers, biochemistry, lymphocyte subsets, immunoglobulins, and complement), and four coronary and treatment outcome variables. Rigorous de-identification was applied: all direct identifiers and exact dates were removed; age is released in integer months; calendar year is released only as era categories; row order was randomly permuted; and extreme timing values were top-coded at 21 days. A full data dictionary, missing-data summary, de-identification protocol, and residual re-identification risk assessment are provided in the accompanying README file.An executable Python script (reproduce_analyses.py) is included, which reproduces all primary and sensitivity analyses reported in the article &amp;mdash; including group comparisons (reference: 5&amp;ndash;7 days), multivariable logistic regression with standardized covariates, nonlinearity likelihood-ratio tests, era-stratified analyses (2012&amp;ndash;2018 vs. 2019&amp;ndash;2025), and a sensitivity analysis restricted to complete KD &amp;mdash; using only pandas, numpy, scipy, and statsmodels.Access: Controlled access under a data-use agreement (non-commercial academic research only; no re-identification attempts; no onward redistribution). Requests should be sent to the corresponding author and will be acknowledged within 30 days.Ethics: Approved by the Institutional Review Board of Wuhan Children's Hospital (2024R034-E01), with a waiver of informed consent for de-identified retrospective data.</dc:description>
  <dc:subject>Kawasaki disease; intravenous immunoglobulin; fever-to-IVIG interval; IVIG resistance; coronary artery dilation; coronary artery aneurysm; treatment timing; retrospective cohort; pediatric cardiology</dc:subject>
  <dc:creator>Changjian Li</dc:creator>
  <dc:creator>Yong Zhang</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>